🧫
Phase I trial of NP137 in advanced endometrial cancer
experiment
Created: 2026-04-10 14:41:11
By: experiment_extractor
Quality:
95%
✓ SciDEX
ID: experiment-exp-0854c675-3027-47a4-971e-0
🧫 Experiment Protocol
Clinical Trial
Related Entities
Metadata
| experiment_type | clinical_trial |
| protocol | Phase I dose-escalation trial with NP137 monotherapy |
| expected_outcomes | Demonstrated safety and clinical activity in advanced EC |
| success_criteria | Objective response rate and stable disease achievement |
| sample_size | 14 |
| statistical_methods | RECIST v.1.1 response criteria |
| p_value | None |
| effect_size | 57.1% stable disease rate, 7.1% objective response rate |
| extracted_at | 2026-04-10T07:41:11.301545 |
| source_pmid | 37532934 |
| _origin | {'type': 'internal', 'url': None, 'tracked_at': '2026-04-10T14:41:11.364750'} |
🌍 Provenance Graph
2 nodes, 1 edges
derives from (1)
Linked Artifacts (22)